Fredun Pharmaceuticals Delivers Robust FY26 Performance; Revenue Jumps 40%, EBITDA Surges 72% and Profit Rises ~60% YoY
Mumbai (Maharashtra) [India], May 25: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of the leading pharmaceutical formulation manufacturing companies in India, diversified across generics, cosmeceuticals, nutraceuticals, mobility, and animal healthcare products, has reported its audited financial results for Q4 FY26 and FY26. Q4 FY26 Standalone Key Financial Highlights Total Income of ₹ 213.05 Cr, YoY growth […]
Continue Reading